The Traderszone Network

Published in TZ Latest News 4 November, 2016 by The TZ Newswire Staff

HSBC downgrades Teva on uncertainty surrounding DOJ’s reported generic drug investigation

HSBC downgrades Teva Pharmaceuticals to hold from buy as investors are likely to “shoot first and ask questions later.”